>MKPCJEJK_00001 Extracellular matrix-binding protein ebh
MEDTLIDSETTRTAVNHDLTEAQALDQLMDTLQQSIADKDATRASSAYVNAEPNKKQAYD
EAVQNAESIIAGLTNPTINKGNVSSATQAVTSSKNALDGVERLAQDKQTAGNSLNHLDQL
TPAQQQALENQINNATTRDKVAEIIAQAQALNEAMKALKESIKDQPQTEASSKFINEDQA
QKDAYTQAVQHAKDLINKTTDPTLAKSIIDQATQAVTDAKNNLHGDQKLAQDKQRATETL
NNLSNLNTPQRQALENQINNAATRDEVAQKLTEAQALNQAMEALRNSIQDQQQTEAGSKF
INEDKPQKDAYQAAVQHAKDLINQTSNPTLDKAQVEQLTQAVNQAKDNLHGDQKLADDKQ
HAVTDLNQLNGLNNPQRQALESQINNAATRGEVAQKLTEAQALNQAMEALRNSIQDQQQT
ESGSKFINEDKPQKDAYQAAVQNAKDLINQTGNPTLDKSQVEQLTQAVTTAKDNLHGDQK
LARDQQQAVTTVNALPNLNHAQQQALTDAINAAPTRTEVAQHVQTATELDHAMETLKNKV
DQVKTDKAQPNYTEASTDKKEAVDQALQAAQSITEPNNGSNANKDAVEQALTKLQEKENE
LNGNERVAEAKTQAKQTVDQLTHLNADQIATAKQNIDQAMKLQPIA
>MKPCJEJK_00002 Extracellular matrix-binding protein EbhA
MDQLQQAVNDHTNVEQTVDYTQADSDKQNAYKQAIADAENVLKQNANKEQVDQALQNILN
AKQALNGDERVALAKTNGKHDIDQLNTLNNAQQDGFKGRIDQSNDLNEIKQIVDEAKALN
RAMNQLSQEITGNEGRTKGSTNYVNADTQVKRVYDDAVDKAKEALNKATGQNLTAEEVIK
LNDAVTAAKQALNGEERLNKRKSEALQRLDQLTHLNNAQRQLATQQINNAETLNKASRAI
NRAVQLDDAMGAVQQYIDDHHFDVISSTNYINADDNLKANYDNAITNAAHELDKVQGSAI
TKAEAEQLKQNIIDAQQALNGDQNLATAKDKANAFVDTLNGLNQQQQDLAHQAINNADTV
TGIANIINDQIDLNNAMETLKHLVDNEIPTAEQTINYQNADDVAKSIFDDAKRLANTLLN
SDNTNVNDINGAIQAVNDAIQNLNGDQRLQEAKDKAIQNVNKVLADKLKEIEASNATDQD
KLIAKNKAEELANSIINNINKATSNQDVSQVQTAGNHAIEQVHANEIPKAKIDANKDADK
QVQALIDEIDRNPNLTDKEKQALKDRINQILQQGHNGINNAMTKEEIEQAKAQLAQALQE
IKDLVKAKENAKQDVDKQVQALIDEIDRNPNLTDKEKQALKDRINQILQQGHNGINNAMT
KEEIEQAKAQLAQALQEIKDLVKAKENAKQDVDKQVQALIDEIDRNPNLTDKEKQALKDR
INQILQQGHNGINNAMTKEEIEQAKAQLAQALQEIKDLVKAKENAKNAIKALANAKRDQI
NSNPDLTPEQKAKALKEIDEAEKRALENIENAQTKDQLNQGLNLGLDDIRNTHVWEVDTQ
PAVNEIFDATPEQILVNGELIVHRDDIITEQDILAHINLVDQLTAEVIDTPSTATISDSL
TAKVEVTLLDGSKVIVNVPVKVVEKELAVVKQQAIESIENAAQQKINDINNHATLTPEQK
EAAIAEVNKLKQQAIEQINNATDVHSVEEVQQQEQTHIEQFNPEQFTIDQAKSNAIKSIT
DAIQHMIDEINASKDLTDKEKQEAISKLNQLKEQAIQAIQRAQSIDEITQQLEQFKAQIK
AANPFAKELEKRKKVAISKIKDISTDAIERIKNSSTGTAEERQAAMNRINEIVLETIRDI
NNAQTPQQVEAALNNGIARILAVQIVTSNNSKHSSDSDGESNSHISIGYGTVNHPFNSSA
IGHKKKLDQDDEIDPLHMRHFGDRIGNVIKNALGVVGISGLLASFWFFIAKRRRKEDEEE
ELEIRDNSKDKKKGSIEGTKHLPLLLAKRRRKEDEEDAIVEEKDSLNNNESLDKVKHTPF
FLPKRRRKEDEEDVEVTNENTDEKVLQDNEHSPLLIAKRRKDKEVDVETTPSIESNEDDA
PLLLAKKKNQKDNQSKGKKSASKKPSKKLVAKKKKKKSKKNKK
>MKPCJEJK_00003 14.7 kDa ribonuclease H-like protein
MAKINFDAATKGNPGISTCAVVIKEDDQHYTYTHELGEMDNHTAEWAACIYALKHARELN
VSNALLYTDSKLIADSVNAGYVKNAKFKPYFDQLEIFEQDFDLLFVKWIPREQNKEANQN
AQQALYKLIKKNK
>MKPCJEJK_00004 queuosine precursor transporter
MYNEILGLVTFIATFVLMVLMYRFFGKQGLIAWVAIGTIIANIQVIKTVEIFGISATLGN
VMFASIYLATDILNDIYGRRVAKRAVWLGFSSTLIMIIVMQLSLHFIPAPEDMAQKALHA
IFDVVPRIALGSIVAYIIGQHIDVFIFSLIKKVFSSDKTFFIRAYGSTFLSSIIDTALFV
AIAFIGSLPGTVVFEIFITTYVLKLASTVFNVPFGYIAKSFYRKGKIDKLDQGY
>MKPCJEJK_00005 hypothetical protein
MQIISISETPNHNTMKITLSESREGMTSDTYTKVDDSQPAFINDILKVEGVKSIFHVMDF
ISVDKENDANWETVLPKVEAVFE
>MKPCJEJK_00006 hypothetical protein
MEILRIEPTPSPNTMKVVLSYTREDKLSNTYKKVEENQPRFINQLLSIDGITSIFHVMNF
LAVDKAPKADWEVILPDIKAAFSGESQVLESGKDPQIDKHFGEIKAELLTFKGIPYQIKL
TSADQELREQLPQTYVDHMTQAQTEHDNIVFMRKWLDLGNRYGNIEEVMDGVLEEVLATY
PESQLPVLVKHALEENHAANNYHFYRHVSLDEYHATDNWKTRLRMLNHFPKPTFEDIPLL
DLALSDEKVPVRRQAIVLLGMIESKEILPYLYKGLRDKSPAVRRTAGDCISDLGYPEALP
EMVLLLDDSQKIVRWRAAMFIFDEGNAEQLPALKAHINDNAFEVKLQIEMAISRIENGDE
ALGSVWKQMANRTI
>MKPCJEJK_00007 hypothetical protein
MNAYDAYMKEIAQQMRGELTQNGFTSLETSEAVLEYMNQVNADDTTFVVINSTCGCAAGL
ARPAAVAVATQNEHRPTNTVTVFAGQDKEATATMREFIQQVPSSPSYALFKGQDLVYFMP
REFIEGRDINDIAMDLKDAFDENCK
>MKPCJEJK_00008 Thymidylate synthase
MLNSFDAAYHSLCEEVLEIGNTRNDRTNTGTISKFGHQLRFDLSKGFPLLTTKKVSFKLV
ATELLWFIKGDTNIQYLLKYNNNIWNEWAFENYIKSDEYKGPDMTDFGHRALSDPEFNEQ
YKEQMKQFKQRILEDDTFAKQFGDLGNVYGKQWRDWVDKDGNHFDQLKTVIEQIKHNPDS
RRHIVSAWNPTEIDTMALPPCHTMFQFYVQDGKLSCQLYQRSADIFLGVPYNIASYALLT
HLIAKECGLEVGEFVHTFGDAHIYSNHIDAIQTQLARESFNPPTLKINSDKSIFDINYED
LEIVDYESHPAIKAPIAV
>MKPCJEJK_00009 Dihydrofolate reductase
MTLSILVAHDLQRVIGFENQLPWHLPNDLKHVKKLSTGHTLVMGRKTFESIGKPLPNRRN
VVLTSDTSFNVEGVDVIHSIEDIYQLPGHVFIFGGQTLFEEMIDKVDDMYITVIEGKFRG
DTFFPPYTFEDWEVTSSVEGKLDEKNTIPHTFLHLIRKK
>MKPCJEJK_00010 DegV domain-containing protein
MTKQIIVTDSTSDLSKEYLEANNIHVIPLSLTIEGVSYVDQVDITSEEFINHIENDEDVK
TSQPAIGEFISAYEELGKDGSEIISIHLSSGLSGTYNTAYQASQMVDANVTVIDSKSISF
GLGYQIQHLVELVKEGVSTSEIVKKLNHLRENIKLFVVIGQLNQLIKGGRISKTKGLIGN
LMKIKPIGTLDDGRLELVHNARTQNSSIQYLKKEIAEFIGDHEIKSVGVTHANVIEYVDK
LKKVFNEAFHVNNYDINVTTPVISAHTGQGAIGLVVLKK
>MKPCJEJK_00011 Peptide methionine sulfoxide reductase MsrA 2
MTKEYATLAGGCFWCMVKPFTSYPGIKSVVSGYSGGHVDNPTYEQVCTNQTGHVEAVQIT
FDPEVTSFENILDIYFKTFDPTDDQGQFFDRGESYQPVIFYHDEHQKKAAEFKKQQLNEQ
GIFKKPVITPIKPYKNFYPAEDYHQDYYKKNPVHYYQYQRGSGRKAFIESHWGNQNA
>MKPCJEJK_00012 Peptide methionine sulfoxide reductase MsrB
MLKKDKSELTDIEYIVTQENGTEPPFMNEYWNHFAKGIYVDKISGKPLFTSEEKFHSECG
WPSFSKALDDDEIIELVDKSFGMVRTEVRSEESNSHLGHVFNDGPKESGGLRYCINSAAI
QFIPYEKLEELGYGDLISHFDK
>MKPCJEJK_00013 PTS system glucose-specific EIIA component
MFKKLFGKGKEVQKDIAIYAPLTGEYVKIEDIPDPVFAQKMMGEGFGINPTEGEVVSPIA
GRVDNVFPTKHAIGLKADNGLELLVHIGLDTVQLDGEGFEVLVSSGDEVNVGDPLVRFNL
EFINNNAKSVISPIIITNTDQAASINIYDENAVIKGETKVIDVTMN
>MKPCJEJK_00014 hypothetical protein
MKNYSFYQFVMTVRGRHDDKGRLAEEIFDDLAFPKHDDDFNILSDYIETHGDFTLPMSVF
DDLYEEYTEWLKF
>MKPCJEJK_00015 putative CtpA-like serine protease
MDDKQHTSSSDDERAEIATSNQDQQTNSSKRVHLKRWQFISILIGTILITAVITVVAYIF
INQKISGLNKTDQANLNKIENVYKILNSDYYKKQDSDKLSKAAIDGMVKELKDPYSEYLT
KEQTKSFNEGVSGDFVGIGAEMQKKNDQIMVTSPMKGSPAERAGIRPKDVITKVNGKSIK
GKALDEVVKDVRGKENTEVTLTVQRGSEEKDVKIKREKIHVKSVEYKKKDKVGVITINKF
QNDTSGELKDAVLKAHKDGLKKIVLDLRNNPGGLLDEAVKMANIFIDKGKTVVKLEKGKD
TEAIQTSNDSLKEAKDMDISILVNEGSASASEVFTGALKDYNKAKVYGSKTFGKGVVQTT
REFKDGSLLKYTEMKWLTPDGHYIHGKGIKPDVTIDTPKYQSLNVIPNTKTFKVGDDDKN
IKTIKIGLSALGYKVDNESTQFDQALENQVKAFQQTNKLEVTGEFNKETNNKFTELLVEK
ANKHDDVLDKLINILK
>MKPCJEJK_00016 hypothetical protein
MIRLGKMSDLDQILNLVEEAKELMKEHDNEQWDDQYPLLEHFEEDIAKDYLYVLEENNKI
YGFIVVDQDQAEWYDDIDWPVNREGAFVIHRLTGSKEYKGAATELFNYVIDVVKARGAEV
ILTDTFALNKPAQGLFAKFGFHKVGEQLMEYPPYDKGEPFYAYYKNLKE
>MKPCJEJK_00017 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MKKIAFTGGGTVGHVSVNLSLIPTALSQGYEALYIGSKNGIEREMIESQLPEIKYYPISS
GKLRRYISLENAKDVFKVLKGILDARKVLKKEKPDLLFSKGGFVSVPVVIAAKSLNIPTI
IHESDLTPGLANKIALKFAKKIYTTFEETLNYLPKEKADFIGATIREDLKNGNAHNGYQL
TGFNENKKVLLVMGGSLGSKKLNSIIRENLDALLQQYQVIHLTGKGLKDAQVKKSGYIQY
EFVKEELTDLLAITDTVISRAGSNAIYEFLTLRIPMLLVPLGLDQSRGDQIDNANHFADK
GYAKAIDEEQLTAQILLQELNEMEQERTRIINNMKSYEQSYTKEALFDKMIKDALN
>MKPCJEJK_00018 hypothetical protein
MSQWKRISLLIVFTLVFGIIAFFHESRLGKWIDNEVYEFIYSSESFITTSIMLGATKVGE
VWAMLCISLLLVAYLMLKRHKIEALFFALTMALSGILNPVLKNIFDRERPTLLRLIDITG
FSFPSGHAMGSTAYFGSGIYLLKRLNQGNSKGILIGLCAAMILLISISRVYLGVHYPTDI
IAGIIGGVFCIILSTLLLRNKLIN
>MKPCJEJK_00019 hypothetical protein
MTNPTRTKRCGGDVLCGIDNHFQLLLYISENHCQLETKTFFEYFLRIVNKTHDYAILENK
KICISH
>MKPCJEJK_00020 Response regulator ArlR
MTQILIVEDEQNLARFLELELTHENYNVDTEYDGQDGLDKALSHYYDLIILDLMLPSING
LEICRKIRQQQSTPIIIITAKSDTYDKVAGLDYGADDYIVKPFDIEELLARIRAILRRQP
QKDIIDVNGITIDKNAFKVTVNGAEIELTKTEYDLLYLLAENKNHVMQREQILNHVWGYN
SEVETNVVDVYIRYLRNKLKPYDRDKMIETVRGVGYVIR
>MKPCJEJK_00021 Signal transduction histidine-protein kinase ArlS
MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKT
VKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGI
EYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQI
TKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDA
SHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVND
ISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAI
KYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLG
LSIAQKIIQLNGGSIKIKSEINKGTTFKIIF
>MKPCJEJK_00022 2-oxoglutarate dehydrogenase E1 component
MTNERKEVSEAPVNFGANLGLMLDLYDDFLQDPSSVPEDLQVLFSTIKNDDSIVPALKST
SSQNSDGTIKRVMRLIDNIRQYGHLKADIYPVNPPKRKHVPKLEIEDFDLDQQTLEGISA
GIVSDHFADIYDNAYEAILRMEKRYKGPIAFEYTHINNNTERGWLKRRIETPYKVTLNNN
EKRALFKQLAYVEGFEKYLHKNFVGAKRFSIEGVDALVPMLQRTITIAAKEGIKNIQIGM
AHRGRLNVLTHVLEKPYEMMISEFMHTDPMKFLPEDGSLQLTAGWTGDVKYHLGGIKTTD
SYGTMQRIALANNPSHLEIVAPVVEGRTRAAQDDTQRAGAPTTDHHKAMPIIIHGDAAYP
GQGINFETMNLGNLKGYSTGGSLHIITNNRIGFTTEPIDARSTTYSTDVAKGYDVPIFHV
NADDVEATIEAIDIAMEFRKEFHKDVVIDLVGYRRFGHNEMDEPSITNPVPYQNIRKHDS
VEYVFGKKLVNEGVISEDEMHSFIEQVQKELRQAHDKINKADKMDNPDMEKPAELALPLQ
ADEQSFTFDHLKEINDALLTYPDGFNILKKLNKVLEKRHEPFNKEDGLVDWAQAEQLAFA
TILQDGTPIRLTGQDSERGTFSHRHAVLHDEQTGETYTPLHHVPDQKATFDIHNSPLSEA
AVVGFEYGYNVENKKSFNIWEAQYGDFANMSQMIFDNFLFSSRSKWGERSGLTLFLPHAY
EGQGPEHSSARLERFLQLAAENNCTVVNLSSSSNYFHLLRAQAASLDSEQMRPLVVMSPK
SLLRNKTVAKPIDEFTSGGFEPILTESYQADKVTKVILATGKMFIDLKEALAKNPDESVL
LVAIERLYPFPEEEIEALLAQLPNLEEVSWVQEEPKNQGAWLYVYPYVKVLVADKYDLSY
HGRIQRAAPAEGDGEIHKLVQNKIIENALKNN
>MKPCJEJK_00023 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MPEVKVPELAESITEGTIAEWLKNVGDSVEKGEAILELETDKVNVEVVSEEAGVLSEQLA
SEGDTVEVGQAIAIIGEGSGNASKENSNDNTPQQNEETNNKKEETTNNSVDKAEVNQAND
DNQQRINATPSARRYARENGVNLAEVSPKTNDVVRKEDIDKKQQAPASTQTTQQAPAKEE
KKYNQYPTKPVIREKMSRRKKTAAKKLLEVSNNTAMLTTFNEVDMTNVMELRKRKKEQFM
KDHDGTKLGFMSFFTKASVAALKKYPEVNAEIDGDDMITKQYYDIGVAVSTDDGLLVPFV
RDCDKKNFAEIEAEIANLAVKAREKKLGLDDMVNGSFTITNGGIFGSMMSTPIINGNQAA
ILGMHSIITRPIAIDQDTIENRPMMYIALSYDHRIIDGKEAVGFLKTIKELIENPEDLLL
ES
